Herpes study and resources.
D015075:2-Aminopurine / Q000627:therapeutic use; D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001704:Biopolymers / Q000627:therapeutic use*; D002392:Catechin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000529:Complementary Therapies; D003195:Computer Communication Networks; D004352:Drug Resistance, Microbial; D000077595:Famciclovir; D017245:Foscarnet / Q000009:adverse effects / Q000627:therapeutic use; D005782:Gels; D015658:HIV Infections / Q000150:complications; D006558:Herpes Genitalis / Q000188:drug therapy* / Q000517:prevention & control* / Q000635:transmission; D006561:Herpes Simplex / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission; D018259:Herpesvirus 1, Human / Q000187:drug effects; D018258:Herpesvirus 2, Human / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D014271:Trifluridine / Q000627:therapeutic use; D044945:Proanthocyanidins
D015075:2-Aminopurine; D000212:Acyclovir; D000998:Antiviral Agents; D001704:Biopolymers; D002392:Catechin; D000077595:Famciclovir; D017245:Foscarnet; D005782:Gels; D014271:Trifluridine; C546704:crofelemer; D044945:Proanthocyanidins